These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1656094)

  • 1. Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones.
    Oyaizu N; Chirmule N; Ohnishi Y; Kalyanaraman VS; Pahwa S
    J Virol; 1991 Nov; 65(11):6277-82. PubMed ID: 1656094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human immunodeficiency virus type-1 envelope glycoprotein gp160 on cytokine production from cord-blood T cells.
    Than S; Oyaizu N; Pahwa RN; Kalyanaraman VS; Pahwa S
    Blood; 1994 Jul; 84(1):184-8. PubMed ID: 8018916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
    Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6.
    Chirmule N; Kalyanaraman VS; Lederman S; Oyaizu N; Yagura H; Yellin MJ; Chess L; Pahwa S
    J Immunol; 1993 Mar; 150(6):2478-86. PubMed ID: 8450224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells.
    Koka P; He K; Camerini D; Tran T; Yashar SS; Merrill JE
    J Neuroimmunol; 1995 Mar; 57(1-2):179-91. PubMed ID: 7706435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41.
    Chirmule N; Kalyanaraman VS; Saxinger C; Wong-Staal F; Ghrayeb J; Pahwa S
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):299-305. PubMed ID: 2187499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS pathogenesis: HIV envelope and its interaction with cell proteins.
    Habeshaw JA; Dalgleish AG; Bountiff L; Newell AL; Wilks D; Walker LC; Manca F
    Immunol Today; 1990 Nov; 11(11):418-25. PubMed ID: 2078296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination.
    Shiver JW; Perry HC; Davies ME; Freed DC; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():198-208. PubMed ID: 8546393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
    Moore JP; McKeating JA; Jones IM; Stephens PE; Clements G; Thomson S; Weiss RA
    AIDS; 1990 Apr; 4(4):307-15. PubMed ID: 2190605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.
    Callahan LN; Phelan M; Mallinson M; Norcross MA
    J Virol; 1991 Mar; 65(3):1543-50. PubMed ID: 1995952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
    Berman PW; Gregory TJ; Riddle L; Nakamura GR; Champe MA; Porter JP; Wurm FM; Hershberg RD; Cobb EK; Eichberg JW
    Nature; 1990 Jun; 345(6276):622-5. PubMed ID: 2190095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme immunoassay (ELISA) for the evaluation of antibodies directed to the CD4 receptor-binding site of the HIV gp120 molecule.
    Hinkula J; Gidlund M; Persson C; Osterhaus A; Wahren B
    J Immunol Methods; 1994 Sep; 175(1):37-46. PubMed ID: 7523525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA.
    Oyaizu N; Chirmule N; Kalyanaraman VS; Hall WW; Pahwa R; Shuster M; Pahwa S
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2379-83. PubMed ID: 2315327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients.
    Oh SK; Cruikshank WW; Raina J; Blanchard GC; Adler WH; Walker J; Kornfeld H
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):251-6. PubMed ID: 1740750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion.
    Oyaizu N; McCloskey TW; Than S; Hu R; Kalyanaraman VS; Pahwa S
    Blood; 1994 Oct; 84(8):2622-31. PubMed ID: 7522637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells.
    Chirmule N; Goonewardena H; Pahwa S; Pasieka R; Kalyanaraman VS; Pahwa S
    J Biol Chem; 1995 Aug; 270(33):19364-9. PubMed ID: 7642615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
    Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.